Evokai Creative Labs, Inc. (OKAI.H.V)
0.115
0.00 (0.00%)
CAD |
TSXV |
Oct 02, 16:00
Evokai Creative Labs Max Drawdown (5Y) : 99.47% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 99.47% |
| August 31, 2026 | 99.47% |
| July 31, 2026 | 99.47% |
| June 30, 2026 | 99.47% |
| May 31, 2026 | 99.47% |
| April 30, 2026 | 99.47% |
| March 31, 2026 | 99.47% |
| February 28, 2026 | 99.47% |
| January 31, 2026 | 99.47% |
| December 31, 2025 | 99.47% |
| November 30, 2025 | 99.47% |
| October 31, 2025 | 99.47% |
| September 30, 2025 | 99.47% |
| August 31, 2025 | 99.47% |
| July 31, 2025 | 99.47% |
| June 30, 2025 | 99.47% |
| May 31, 2025 | 99.47% |
| April 30, 2025 | 99.47% |
| March 31, 2025 | 99.47% |
| February 28, 2025 | 99.30% |
| January 31, 2025 | 99.07% |
| December 31, 2024 | 99.07% |
| November 30, 2024 | 99.07% |
| October 31, 2024 | 98.84% |
| September 30, 2024 | 98.84% |
| Date | Value |
|---|---|
| August 31, 2024 | 98.60% |
| July 31, 2024 | 97.21% |
| June 30, 2024 | 97.21% |
| May 31, 2024 | 96.51% |
| April 30, 2024 | 96.51% |
| March 31, 2024 | 96.51% |
| February 29, 2024 | 96.51% |
| January 31, 2024 | 96.51% |
| December 31, 2023 | 96.51% |
| November 30, 2023 | 65.33% |
| October 31, 2023 | 71.29% |
| September 30, 2023 | 78.22% |
| August 31, 2023 | 84.07% |
| July 31, 2023 | 93.68% |
| June 30, 2023 | 93.68% |
| May 31, 2023 | 93.68% |
| April 30, 2023 | 93.68% |
| March 31, 2023 | 95.49% |
| February 28, 2023 | 95.49% |
| January 31, 2023 | 95.49% |
| December 31, 2022 | 95.49% |
| November 30, 2022 | 95.49% |
| October 31, 2022 | 95.49% |
| September 30, 2022 | 95.49% |
| August 31, 2022 | 95.49% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Diagnos, Inc. | 83.33% |
| Arch Biopartners, Inc. | 91.80% |
| Avricore Health, Inc. | 93.22% |
| Kane Biotech, Inc. | 89.47% |
| CardioComm Solutions, Inc. | 95.00% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -45.80 |
| Beta (5Y) | -0.4166 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 136.7% |
| Historical Sharpe Ratio (5Y) | -0.3689 |
| Historical Sortino (5Y) | -0.8527 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 38.46% |